Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction

Japanese Circulation Journal

Volumn 61, Issue 1, 1997, Pages 38-45

  Ishikawa, Kinji ^a   Kanamasa, Ken ^a   Hama, Junkichi ^a   Ogawa, Iwao ^a   Takenaka, Toshihiko ^a   Naito, Takeo ^a   Yamamoto, Tadahiko ^a   Nakai, Shoji ^a   Oyaizu, Miki ^a   Kimura, Akio ^a   Yamamoto, Kentaro ^a   Katori, Ryo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aspirin; Cardiac events; Dipyridamole; Recurrent myocardial infarction; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; TICLOPIDINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; THROMBOCYTE ACTIVATION;

AGED; ASPIRIN; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; TICLOPIDINE;

EID: 3042988419     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.61.38     Document Type: Article

References (24)

1. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106
2. Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ et al: Preventing heart attack and death in patients with coronary disease. Circulation 1995; 92: 2-4
3. Klimt CR, Knatterud GL, Stamler J, Meier P: Persantine-Aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol 1986; 7: 251-269
4. Nagakawa Y, Akedo Y, Orimo H, Yano H: Effect of the combination of antiplatelet agents in man: Combination of aspirin, trapidil, ticlopidine and dipyridamole. Thromb Res 1990; 60: 469-475
5. De Caterina R, Sicari R, Bernini W, Lazzerini G, Strata GB, Giannessi D: Benefit J risk profile of combined antiplatelet therapy with ticlopidine and aspirin. Thromb Haemost 1991; 65: 504-510
6. Basile AP, Fiala TGS, Yaremchuk MJ, May JW Jr: The antithrombotic effects of ticlopidine and aspirin in a microvascular thrombogenic model. Plast Reconstr Surg 1995; 95: 1258-1264
7. Uchiyama S, Sone R, Nagayama T, Shibagaki Y, Kobayashi I, Maruyama S et al: Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia. Stroke 1989; 20: 1643-1647
8. Patrono C: Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 1287-1294
9. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N et al: Aspirin 50 mg/day with either dipyridamole or ticlopidine significantly reduced recurrent myocardial infarction (abstract). Circulation 1991; 84: II-367
10. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N et al: Aspirin 50 mg/day combined with either dipyridamole or ticlopidine is effective to prevent recurrent myocardial infarction (abstract). Circulation 1992; 86: 1-643
11. Ishikawa K, Kanamasa K, Hama J, Ogawa I, Takenaka T, Naito T et al: Effects of drugs on preventing recurrent myocardial infarction in patients with healed myocardial infarction. Jpn Circ J 1994; 58(Suppl IV): 1288-1292
12. Forrester JS, Diamond GA, Swan HJC: Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977; 39: 137-145
13. Killip T III, Kimball JT: Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 1967; 20: 457-464
14. Heger JJ, Weyman AE, Wann LS, Rogers EW, Dillon JC, Feigenbaum H: Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction. Circulation 1980; 61: 1113-1118
15. Wagner GS, Freye CJ, Palmeri ST, Roark SF, Stack NC, Ideker RE et al: Evaluation of a QRS scoring system for estimating myocardial infarct size. Circulation 1982; 65: 342-347
16. Myerburg RJ, Castellanos A: Cardiac arrest and sudden cardiac death. In: Braunwald E, editor. Heart Disease, Philadelphia, WB Saunders, 1992; vol 1, 756-789
17. Miettinen OS: Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226-235
18. Steering Committee of The Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989; 321: 129-135
19. Hoffmann W, Förster W: Zweijahresstudie an den Herzinfarkt-Patienten des Bezirkes Cottbus mit 30, 60 und 1,000 mg Acetylsalicylsäure (ASS) je Tag-Einfluß auf Reinfarkt-Morbidität und Letalität. Z Klin Med 1987; 42: 2097-2101
20. Rajah SM, Penny AF, Crow MJ, Watson PDA: The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time. Br J Clin Pharmacol 1979; 8: 483-489
21. Best LC, McGuire MB, Jones PBB, Holland TK, Martin TJ, Preston FE et al: Mode of action of dipyridamole on human platelets. Thromb Res 1979; 16: 367-379
22. Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M: Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983; 50: 852-856
23. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S et al: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. W Engl J Med 1989; 321: 501-507
24. Balsano F, Rizzon P, Violi F, Scrutinio D, Cimminiello C, Aguglia F et al: Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. Circulation 1990; 82: 17-26